Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Digestive Diseases (Basel, Switzerland)|August 23, 2016
Any Future for Fecal Microbiota Transplantation as Treatment Strategy for Inflammatory Bowel Diseases?Patrizia Kump, Christoph Högenauer
Gastroenterology Clinics of North America|August 25, 2012
Diarrhea caused by circulating agentsElisabeth Fabian, Patrizia Kump, Guenter J Krejs
European Journal of Nutrition|September 26, 2018
Effects of an oral synbiotic on the gastrointestinal immune system and microbiota in patients with diarrhea-predominant irritable bowel syndromeAdrian Mathias Moser, Walter Spindelboeck, Bettina Halwachs, et al.
Case Reports in Oncology|February 13, 2018
Downgrading of a G3 Neuroendocrine Tumor to a G2 Tumor: Can First-Line Cytotoxic Chemotherapy Change the Tumor Biology?Andreas Blesl, Elisabeth Krones, Marion J Pollheimer, et al.
Scandinavian Journal of Gastroenterology|June 22, 2022
Treatment persistence of ustekinumab and vedolizumab in IBD patients is independent of prior immunogenicity to anti-TNFs: a retrospective studyAndreas Blesl, Wolfgang Petritsch, Lukas Binder, et al.
Medicine|April 9, 2016
Successful Medical Treatment of Adult Nesidioblastosis With Pasireotide over 3 Years: A Case ReportVerena Schwetz, Karl Horvath, Patrizia Kump, et al.
Alimentary Pharmacology & Therapeutics|June 21, 2021
Limited long-term treatment persistence of first anti-TNF therapy in 538 patients with inflammatory bowel diseases: a 20-year real-world studyAndreas Blesl, Lukas Binder, Christoph Högenauer, et al.
Microbiology Spectrum|May 13, 2024
Rapid biotransformation of STW 5 constituents by human gut microbiome from IBS- and non-IBS donorsTimo A Thumann, Eva-Maria Pferschy-Wenzig, Christina Kumpitsch, et al.
Pageof 3